Empagliflozin (trade name: Jardiance) is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2). Empagliflozin is used for the treatment of type 2 diabetes in adults. Empagliflozin has been approved by the U.S Food and Drug Administration on August 1, 2014.
Product Name: Empagliflozin
CAS Number: 864070-44-0
Molecular Weight:  450.9151
Molecular Formula:  C23H27ClO7
Purity (HPLC): ≥99%.5
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.